insights_auto
Outlook: 79.0% bullish·0.0% bearish
Go to analysischevron_right
HAE:NYSE
Haemonetics Corp
121,95 $
arrow_downward
-0,09%(-0,11) 1D
13 қаз., 11:52:22 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
122,80 $
High
123,77 $
Low
121,04 $
Mkt. cap
5,55 млрд
Avg. vol.
676,78 м.
Volume
142,56 м.
P/E ratio
59,48
52-wk high
123,77 $
52-wk low
48,55 $
EPS
2,05 $
Beta
0,61
Shares outstanding
45,50 млн
No. of employees
3 мың
Open
122,80 $
High
123,77 $
Low
121,04 $
Mkt. cap
5,55 млрд
Avg. vol.
676,78 м.
Volume
142,56 м.
P/E ratio
59,48
52-wk high
123,77 $
52-wk low
48,55 $
EPS
2,05 $
Beta
0,61
Shares outstanding
45,50 млн
No. of employees
3 мың
News stories
From web sources and news partners
Zacks
·
2 сағат бұрын
Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3,01 мың
Founded1971
HeadquartersБостон, Массачусетс, Америка Құрама Штаттары
SectorMedical device
Websitehaemonetics.com